Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis
CzechiaStudy of Blinatumomab Treatment in Patients with Systemic Lupus Erythematosus, Systemic Sclerosis, or Granulomatosis with Polyangiitis: Safety and Effectiveness Evaluation
GermanyComparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis
GermanyStudy of colchicine to improve insulin sensitivity in adults with type 1 diabetes who have low-grade inflammation
DenmarkStudy of semaglutide for weight loss in adults with type 1 diabetes and obesity
DenmarkStudy on the Effects and Safety of Rilzabrutinib for Adults with Graves' Disease
GermanyStudy on the Effectiveness of Abatacept for Patients with Giant Cell Arteritis
GermanyEffectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis
GermanyStudy on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis
CzechiaStudy on the Effects of THC and CBD Oral Solution for Chronic Neuropathic Pain in Multiple Sclerosis Patients
PortugalStudy on the Effectiveness of Ixekizumab for Patients with Refractory Psoriatic Arthritis
ItalyStudy of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis
AustriaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
